P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells

Arthritis Research and Therapy

Volumn 8, Issue 6, 2006, Pages

  Zaka, Raihana ^a   Stokes, David ^a   Dion, Arnold S ^b   Kusnierz, Anna ^a   Han, Fei ^a   Williams, Charlene J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANK PROTEIN, MOUSE; INORGANIC PYROPHOSPHATASE; MEMBRANE PROTEIN; PHOSPHATE TRANSPORTER;

ANIMAL; CALCINOSIS; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; GENETICS; HYPERTROPHY; METABOLISM; MOUSE; MUTATION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

ALKALINE PHOSPHATASE; ANIMALS; CALCINOSIS; CARTILAGE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; HYPERTROPHY; INORGANIC PYROPHOSPHATASE; MEMBRANE PROTEINS; MICE; MICROSCOPY, CONFOCAL; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHOSPHATE TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 34247550930     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2072     Document Type: Article

References (36)

1. Williams CJ: Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene [review, 43 refs]. Curr Opin Rheumatol 2003, 15:326-331.
2. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis.[see comment]. Science 2000, 289:265-270.
3. Sohn P, Crowley M, Slattery E, Serra R: Developmental and TGF-β mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage 2002, 10:482-490.
4. Hirose J, Ryan LM, Masuda I: Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum 2002, 46:3218-3229.
5. Uzuki M, Ryan LM, Sawai T, Kingsley DM, Masuda I: Up-regulated expression of ANK in joint tissue from patients with calcium pyrophosphate dihydrate crystal deposition disease (CPPD) [abstract]. Arthritis Rheum 2004, 50:S247.
6. Johnson K, Terkeltaub R: Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthritis Cartilage 2004, 12:321-335.
7. Wang W, Xu J, Du B, Kirsch T: Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol 2005, 25 312-323.
8. Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y: Cellular hypertrophy and calcification of embryonal carcinomaderived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res 1997, 12:1174-1188.
9. Atsumi T, Miwa Y, Kimata K, Ikawa Y: A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 1990, 30:109-116.
10. Cham BE, Knowles BR: A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 1976, 17 176-181.
11. Dion AS, Smorodinsky NI, Williams CJ, Wreschner DH, Major PP, Keydar I: Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies. Hybridoma 1991, 10 595-610.
12. Lust G, Seegmiller JE: A rapid, enzymatic assay for measurement of inorganic pyrophosphate in biological samples. Clin Chim Acta 1976, 66:241-249.
13. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, Jin-Hua P, Sali A, Goding J, Terkeltaub R: Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999, 42:1986-1997.
14. Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER: A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem 1983, 29 751-761.
15. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, et al.: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002, 71:933-940.
16. Williams CJ, Pendleton A, Bonavita G, Reginato AJ, Hughes AE, Peariso S, Doherty M, McCarty DJ, Ryan LM: Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 2003, 48:2627-2631.
17. Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J, Cuthbertson J, Jones Y, Marchegiani R, Reginato A, et al.: Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 2002, 71:985-991.
18. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, et al.: Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 2001, 28:37-41.
19. Reichenberger E, Tiziani V, Watanabe S, Park L, Uek Yi, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, et al.: Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet 2001, 68:1321-1326.
20. Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology [review, 128 refs]. Am J Physiol Cell Physiol 2001, 281:C1-C11.
21. Hirose J, Masuda I, Ryan LM: Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum 2000, 43:2703-2711.
22. Olmez U, Ryan LM, Kurup IV, Rosenthal AK: Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage 1994, 2:149-154.
23. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL: Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002, 99 9445-9449.
24. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R: Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1 Am J Physiol Regul Integr Comp Physiol 2000, 279 R1365-R1377.
25. Rosenthal AK, Henry LA: Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol 1999, 26 395-401.
26. Iwamoto M, Shapiro IM, Yagami K, Boskey AL, Leboy PS, Adams SL, Pacifici M: Retinoic acid induces rapid mineralization and expression of mineralization-related genes in chondrocytes. Exp Cell Res 1993, 207:413-420.
27. Lian JB, McKee MD, Todd AM, Gerstenfeld LC: Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem 1993, 52:206-219.
28. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T, Komori T: Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 2000, 275:8695-8702.
29. Kim IS, Otto F, Zabel B, Mundlos S: Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 1999, 80:159-170.
30. Zaka R, Williams CJ: Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol 2006, 18 181-186.
31. Zhang Y, Johnson K, Russell G, Wordsworth P, Carr A, Terkeltaub RA, Brown MA: Association of sporadic chondrocalcinosis with a -4 basepair G to A transition in the ′5 untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum 2005, 52:1110-1117.
32. Yoshimatu T, Saitoh A, Ryu JN, Shima D, Hand H, Hiramoto M, Kawakami Y, Aizawa S: Characterization of immortalized human chondrocytes originated from osteoarthritic cartilage. Int J Mol Med 2001, 8:345-351.
33. Ryan LM, Kurup I, Cheung HS: Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate. Matrix 1991, 11 276-281.
34. Bianchi A, Perrey J, Morin S, Moulin D, Koufany M, Gillet P, Loeuille D, Terlain B, Jouzeau J-Y, Netter P: Growth factors and cytokines modulate Progressive ankylosis gene expression in rat chondrocytes - Ank induction by TGFbeta depends on PKC pathway and ePPi level [abstract] Arthritis Rheum 2004, 50:S248.
35. Johnson K, Goding J, Van Etten D, Sali A, Hsu SI, Farley D, Krug H, Hessle L, Millan JL, Terkeltaub R: Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 2003, 18:994-1004.
36. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL: Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank. Am J Pathol 2004, 164:1199-1209.